TIMOTHY SPEARS: Open Payments
NPI 1639173156 · IOLA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 39 payments from 9 companies in 2025. Trend: 2023 $598 · 2024 $634 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $143 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Organogenesis Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, TRINTELLIX, FARXIGA, JOURNAVX, GEMTESA, PURAPLY WOUND MATRIX, BREZTRI.
Industry payments across KS — which companies pay providers there.
